Study of Periostin, SerpinB2 and CLCA1Gene Expression as Potential Predictors of Corticosteroid Therapy Response in Childhood Asthma
Aly, I., Sobeih, A., Salem, R., Mohammed, D. (2018). Study of Periostin, SerpinB2 and CLCA1Gene Expression as Potential Predictors of Corticosteroid Therapy Response in Childhood Asthma. EKB Journal Management System, 3(1), 139-143. doi: 10.21608/bjas.2018.191102
I.A.M. Aly; A.A. Sobeih; R.F. Salem; D.A. Mohammed. "Study of Periostin, SerpinB2 and CLCA1Gene Expression as Potential Predictors of Corticosteroid Therapy Response in Childhood Asthma". EKB Journal Management System, 3, 1, 2018, 139-143. doi: 10.21608/bjas.2018.191102
Aly, I., Sobeih, A., Salem, R., Mohammed, D. (2018). 'Study of Periostin, SerpinB2 and CLCA1Gene Expression as Potential Predictors of Corticosteroid Therapy Response in Childhood Asthma', EKB Journal Management System, 3(1), pp. 139-143. doi: 10.21608/bjas.2018.191102
Aly, I., Sobeih, A., Salem, R., Mohammed, D. Study of Periostin, SerpinB2 and CLCA1Gene Expression as Potential Predictors of Corticosteroid Therapy Response in Childhood Asthma. EKB Journal Management System, 2018; 3(1): 139-143. doi: 10.21608/bjas.2018.191102

Study of Periostin, SerpinB2 and CLCA1Gene Expression as Potential Predictors of Corticosteroid Therapy Response in Childhood Asthma

Benha Journal of Applied Sciences
Article 24, Volume 3, Issue 1, March 2018, Page 139-143  XML PDF (423.34 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2018.191102
View on SCiNiTO View on SCiNiTO
Authors
I.A.M. Aly1; A.A. Sobeih1; R.F. Salem2; D.A. Mohammed1
1Pediatrics Dept., Faculty of medicine, Benha Univ.,Benha, Egypt
2Biochemistry Dept., Faculty of medicine, Benha Univ.,Benha, Egypt
Abstract
Currently, systemic corticosteroid treatment is considered themost effective medication for control of chronic asthma andrescue of acute exacerbation. Children can have poorly controlled asthma for numerous reasons. It is important to identify the underlying causes that contribute to poorly controlled asthma in each patient so that management strategies can be personalized to achieve the best outcomes. We have identified a biological basis for poor corticosteroid treatment response that can be used to distinguish a subgroup of children with asthma who respond poorly to treatment. nasal Periostin,SerpinB2 and CLCA1Gene expression might be a clinicallyuseful biomarker to identify a subset of children with difficult to-treat asthma with a biologic cause for poor corticosteroid response. Targeting Periostin,SerpinB2 and CLCA1 pathways in this subset might be a useful therapeutic strategy to enhance corticosteroid response.
Statistics
Article View: 81
PDF Download: 251